Sath Shukla - Aug 27, 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
CEO & President
Signature
/s/ Sath Shukla
Stock symbol
SPRO
Transactions as of
Aug 27, 2024
Transactions value $
-$3,722
Form type
4
Date filed
8/29/2024, 06:36 PM
Previous filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Sale -$3.72K -2.76K -0.24% $1.35 1.14M Aug 27, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on August 26, 2021.